Brand Drug Repackaging Helps Drive Extraordinary Price Increases - GAO
Executive Summary
Repackaged versions of many of the most widely prescribed brand-name drugs appear on a list of those with "extraordinary" price increases between 2000 and 2008, data from a recent analysis by the Government Accountability Office show